Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Cash (2018 - 2025)

Historic Change in Cash for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to -$5.3 million.

  • Bio's Change in Cash rose 4258.84% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 13050.74%. This contributed to the annual value of $5.9 million for FY2024, which is 1941.71% up from last year.
  • As of Q3 2025, Bio's Change in Cash stood at -$5.3 million, which was up 4258.84% from -$7.9 million recorded in Q2 2025.
  • In the past 5 years, Bio's Change in Cash registered a high of $35.4 million during Q4 2024, and its lowest value of -$12.2 million during Q4 2022.
  • Over the past 5 years, Bio's median Change in Cash value was -$8.6 million (recorded in 2021), while the average stood at -$2.3 million.
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 76418.45% in 2023, then tumbled by 13029.71% in 2024.
  • Quarter analysis of 5 years shows Bio's Change in Cash stood at -$9.7 million in 2021, then decreased by 25.78% to -$12.2 million in 2022, then increased by 8.18% to -$11.2 million in 2023, then surged by 415.57% to $35.4 million in 2024, then crashed by 114.93% to -$5.3 million in 2025.
  • Its last three reported values are -$5.3 million in Q3 2025, -$7.9 million for Q2 2025, and -$9.8 million during Q1 2025.